In the United States, 6.4% of the population carries a diagnosis of chronic obstructive
pulmonary disease (COPD) and it was the third leading cause of death in 2014. Approximately
75% of these patients present at least once a year to a provider for COPD exacerbation
and most of these receive antibiotics. However, it is well known that antibiotics
can have adverse effects and available evidence suggests that antibiotics are not
always necessary for COPD exacerbation. The objective of this study was to determine
if point of care (POC) CRP utilization to guide antibiotic therapy for COPD exacerbations
in the primary care setting can reduce antibiotic use without harm.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.
